Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "67a35e1c4d6823e26538d21d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)",
"description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"tablet daily",
"balanced diet",
"medication helps",
"nausea diarrhea",
"experience mild",
"body directions",
"significant reduction",
"effective drugs",
"multiple medications",
"weight reduction",
"work synergistically",
"empagliflozin 125mg",
"cases due",
"diabetesrelated complications",
"increased glucose",
"glucose excretion dehydration",
"regular exercise regimen",
"metformin hydrochloride 500mg",
"frequent urination due",
"heartrelated complications linked",
"blood glucose utilization",
"eliminating excess glucose",
"moderate side effects",
"gliempaflozin met 125mg500mg",
"healthcare provider swallow",
"improving glycemic control",
"potent antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2050,
"imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:48:28.684Z",
"updatedon": "2025-03-17T11:04:23.276Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 12.5 mg+metformin 500 mg",
"empagliflozin/metformin 5 mg/1000 mg",
"Empagliflozin 12.5 mg brands in India",
"empagliflozin 12.5 mg+metformin 500 mg price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35d815432f8f0afe662b4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg",
"description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.",
"price": 245.0,
"discountamount": 74.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"combination medication",
"hypoglycemia directions",
"oncedaily dosage",
"difficulty breathing",
"experience mild",
"stop taking",
"healthy diet",
"chew maintain",
"day preferably",
"glycemic control",
"digestive tract",
"sglt2 protein",
"diabetic nephropathy",
"balanced mechanism",
"cardiac complications",
"diabetesrelated complications",
"constipation metallic taste",
"stomach upset diarrhea",
"frequent urination due",
"moderate side effects",
"doctor side effects",
"blood sugar levels",
"regular exercise routine",
"healthcare provider swallow",
"minimizing side effects",
"dual action approach",
"delays glucose absorption",
"improved patient compliance",
"heart health lowering",
"cardiovascular diseases beneficial",
"enhance glucose regulation"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2049,
"imageuri": "https://productimages.withfloats.com/actual/67a35d9d1b599c6f20ba1fa7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35d9d1b599c6f20ba1fa7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:45:53.712Z",
"updatedon": "2025-03-27T09:45:21.627Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-metformin-hydrochloride-extended-release-1000-mg/2049",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN MET ER ",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin/metformin 5 mg/1000 mg",
"empagliflozin + metformin brand name in india",
"empagliflozin + metformin combination brand name",
"empagliflozin 12.5 mg+metformin 500 mg price",
"Empagliflozin and metformin hydrochloride extended-release tablets",
"Empagliflozin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35c945c5e728a14d08ad8",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin (25mg), Linagliptin (5mg)",
"description": "GLIEMPAFLOZIN LINA 25mg/5mg is a combination medication designed for individuals managing type 2 diabetes mellitus. It contains Empagliflozin (25mg) and Linagliptin (5mg), two potent anti-diabetic agents that work together to control blood sugar levels effectively. This medication is typically prescribed to patients who require dual therapy to achieve optimal glycemic control when diet and exercise alone are insufficient.\n\n \nKey Benefits :\n \n\nEffective Blood Sugar Control: Regulates blood glucose levels efficiently in patients with type 2 diabetes.\n\nWeight Management: Empagliflozin promotes weight loss by removing excess glucose from the body.\n\nHeart and Kidney Benefits: Shown to provide cardiovascular and renal protection, reducing the risk of heart failure.\n\nLower Risk of Hypoglycemia: Minimal chances of low blood sugar episodes compared to other anti-diabetic medications.\n\nConvenient Dual Therapy: Combines two complementary mechanisms for enhanced glycemic control in a single tablet.\n\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor): This component blocks Sodium-Glucose Cotransporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and facilitating its elimination through urine. This leads to a significant reduction in blood sugar levels.\n\nLinagliptin (DPP-4 Inhibitor): It inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme, which increases incretin hormone levels. This enhances insulin secretion and suppresses glucagon production, leading to better post-meal glucose control.\n\n \nDirections for Use\n \n\nTake one tablet daily, preferably at the same time each day.\n\nSwallow the tablet whole with water, with or without food.\n\nFollow the dosage regimen prescribed by your healthcare provider.\n\nRegular monitoring of blood sugar levels is recommended.\n\n \nSide Effects\n \n\nAlthough GLIEMPAFLOZIN LINA 25mg/5mg is generally well-tolerated, some patients may experience:\n\nFrequent Urination: Due to glucose excretion through urine.\n\nDehydration or Thirst: Increased urination may lead to mild dehydration.\n\nUrinary Tract Infections (UTIs): A common side effect associated with SGLT2 inhibitors.\n\nNasal Congestion or Sore Throat: Occasionally observed with DPP-4 inhibitors.\n\nGastrointestinal Discomfort: Mild nausea or diarrhea in some cases.\n\nHypotension (Low Blood Pressure): Especially in patients with pre-existing conditions.\n\n ",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"urine dehydration",
"preexisting conditions",
"generally welltolerated",
"food follow",
"day swallow",
"significant reduction",
"single tablet",
"complementary mechanisms",
"provide cardiovascular",
"body heart",
"linagliptin 5mg",
"empagliflozin 25mg",
"glucose excretion",
"typically prescribed",
"tablet daily preferably",
"combination medication designed",
"dosage regimen prescribed",
"removing excess glucose",
"common side effect",
"thirst increased urination",
"gliempaflozin lina 25mg5mg",
"recommended side effects",
"blood sugar levels",
"enhances insulin secretion",
"enhanced glycemic control",
"hypoglycemia minimal chances",
"renal protection reducing",
"kidney benefits shown",
"require dual therapy",
"potent antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2048,
"imageuri": "https://productimages.withfloats.com/actual/67a35cb9b07d7c125c0f536d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35cb9b07d7c125c0f536d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:41:56.39Z",
"updatedon": "2025-03-17T11:04:56.55Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-linagliptin-5mg-/2048",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN LINA 25mg/ 5mg",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin-linagliptin 25-5 mg price",
"Empagliflozin and Linagliptin brands in India",
"empagliflozin-linagliptin 10-5 mg",
"Fixed dose combination of Empagliflozin and Linagliptin Tablets Price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "674b0a7ee34075b8291b14f1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets",
"description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n",
"price": 153.0,
"discountamount": 46.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"prescribed dosage",
"ingredients address",
"glycemic control",
"targets fasting",
"generally welltolerated",
"glimiteris trio 0502500",
"optimal results",
"meals swallow",
"healthcare professional",
"holistic solution",
"multifaceted nature",
"cardiovascular issues",
"neuropathy retinopathy",
"insulin improving",
"bodys response",
"multiple pathways",
"synergistic combination",
"multifaceted approach",
"dosage side effects",
"delaying glucose absorption",
"postprandial blood glucose",
"metformin allergic reactions",
"diarrhea stomach discomfort",
"experience side effects",
"reduce gastrointestinal discomfort",
"work glimepiride stimulates",
"proven antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2016,
"imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-11-30T12:52:14.799Z",
"updatedon": "2024-11-30T12:52:14.799Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS TRIO 0.5/0.2/500 ",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6890aa548a215c65672372e1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH LINA 25/5",
"description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2154,
"imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-04T12:40:52.619Z",
"updatedon": "2025-08-04T12:40:52.619Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin and Linagliptin Tablets",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and Linagliptin Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "683d992c87328f4e892f8716",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH 25",
"description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)",
"price": 225.0,
"discountamount": 68.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"tablet swallow",
"day preferably",
"body aids",
"nausea vomiting",
"medical attention",
"cholesterol levels",
"diuretics dizziness",
"crush chew",
"healthcare provider",
"food follow",
"empatech 25 orally",
"present additionally",
"insulin resistance",
"suitable option",
"insulin making",
"works independently",
"sglt2 protein",
"causing hypoglycemia",
"reduced risk",
"cardiovascular health",
"weight management",
"exercise empatech 25",
"effective treatment",
"empatech 25empatech 25",
"balanced diet",
"empagliflozin 25 mg",
"glycemic control",
"improves glycemic control",
"work empagliflozin blocks",
"selective sglt2 inhibitor",
"alongside proper diet",
"abdominal pain occur",
"reabsorbing glucose back"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2130,
"imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png",
"tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-06-02T12:29:32.123Z",
"updatedon": "2025-06-02T12:31:28.199Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin 25 mg",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 25 mg",
"empagliflozin 25 mg tablet",
"Empagliflozin 25 mg brands in India",
"Empagliflozin 25 mg Price in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67e1538c204f0ac1d74d3bc3",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 10 mg ",
"description": "EMPATECH 10 contains Empagliflozin 10 mg, a highly effective oral medication used for the management of type 2 diabetes mellitus. It helps regulate blood sugar levels by promoting glucose excretion through urine, reducing the risk of complications like heart disease and kidney damage. With its unique action, EMPATECH 10 not only aids in diabetes control but also supports overall cardiovascular and renal health.\n \nKey Benefits:\n\nEffective Blood Sugar Control – Lowers blood glucose levels and improves diabetes management.\nSupports Weight Management – Aids in weight loss by eliminating excess glucose.\nReduces Risk of Cardiovascular Diseases – Helps protect the heart and lower the risk of heart failure.\nPromotes Kidney Health – Prevents diabetic kidney damage by reducing strain on the kidneys.\nLowers Blood Pressure – Has a mild diuretic effect, which helps in managing hypertension.\n\nHow Does It Work?\n\nEmpagliflozin works by inhibiting the SGLT2 protein in the kidneys, preventing glucose reabsorption into the bloodstream. This results in excess glucose being excreted through urine, thereby lowering blood sugar levels naturally. Unlike insulin-based treatments, it works independently of insulin secretion, making it a beneficial option for many patients.\n \nDirections for Use:\n\nTake EMPATECH 10 exactly as prescribed by your doctor.\nSwallow the tablet whole with water, preferably once daily in the morning.\nIt can be taken with or without food.\nMaintain a healthy diet and exercise routine for best results.\nDo not stop the medication without consulting your healthcare provider.\n\nSide Effects:\n\nWhile EMPATECH 10 is generally well-tolerated, some individuals may experience:\nFrequent Urination\nIncreased Thirst\nUrinary Tract Infections (UTIs)\nDizziness or Low Blood Pressure\nGenital Infections (in some cases)\n\nIf you experience severe dehydration, allergic reactions, or persistent infections, seek medical help immediately.",
"price": 135.0,
"discountamount": 41.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"empatech 10",
"heart disease",
"urine reducing",
"generally welltolerated",
"exercise routine",
"healthy diet",
"food maintain",
"water preferably",
"doctor swallow",
"patients directions",
"beneficial option",
"sglt2 protein",
"managing hypertension",
"reducing strain",
"weight loss",
"diabetes control",
"kidney damage",
"empagliflozin 10mg",
"empagliflozin 10mgempatech 10",
"works independently",
"excess glucose",
"work empagliflozin works",
"promoting glucose excretion",
"insulin secretion making",
"mild diuretic effect"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2073,
"imageuri": "https://productimages.withfloats.com/actual/67e1539d6530786450c6e761.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67e1539d6530786450c6e761.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-24T12:43:56.598Z",
"updatedon": "2025-03-27T12:56:57.309Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10-mg-/2073",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EMPATECH 10",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin 10 mg uses",
"Empagliflozin 10 mg brand name",
"Empagliflozin 10 mg brands in India",
"Empagliflozin 10 mg Tablet price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67e151dde76674b1ca044d32",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 25 mg and Sitagliptin 100 mg",
"description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin 25 mg and Sitagliptin 100 mg, formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.",
"price": 425.0,
"discountamount": 128.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"sulfonylureas urinary",
"generally welltolerated",
"recommended dosage",
"regular exercise",
"healthy diet",
"food maintain",
"water preferably",
"doctor swallow",
"gliempaflozin sita 25100",
"superior option",
"mechanisms making",
"incretin hormones",
"dpp4 enzyme",
"supporting heart",
"sglt2 protein",
"diabetes management",
"cardiovascular diseases",
"diabetesrelated complications",
"empagliflozin 25mg",
"reduce glucose production",
"stimulate insulin release",
"work empagliflozin blocks",
"increased sugar excretion",
"genital infections due",
"lowering blood sugar",
"promoting glucose excretion",
"powerful antidiabetic agents",
"sitagliptin 100mg formulated",
"advanced antidiabetic medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2071,
"imageuri": "https://productimages.withfloats.com/actual/67e151f4a5330495f6fabda3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67e151f4a5330495f6fabda3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-24T12:36:45.699Z",
"updatedon": "2025-03-27T13:02:48.654Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25-mg-and-sitagliptin-100-mg/2071",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN SITA 25/100",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and sitagliptin combination",
"Empagliflozin 25 mg substitute",
"Empagliflozin 25 mg brands in India",
"Empagliflozin 25 mg Price in India",
"Empagliflozin brands in India",
"Empagliflozin 25 mg",
"Empagliflozin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35ad2c50c07ee3dcaceda",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg",
"description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.",
"price": 185.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"lower risk",
"nephrons reduces",
"reducing strain",
"weight management",
"diabetes management",
"chest pain",
"doctor immediately",
"lactic acidosis",
"rare cases",
"prolonged metformin",
"nausea diarrhea",
"experience mild",
"crush chew",
"glycemic control",
"mechanisms ensure",
"peripheral tissues",
"kidneys leading",
"diabetes treatments",
"hypoglycemia unlike",
"bodys response",
"heart disease",
"weight loss",
"medication aids",
"regular exercise",
"proper diet",
"biguanide therapy",
"sglt2 inhibition",
"complementary mechanisms",
"empagliflozin dehydration",
"excess glucose",
"eliminating excess glucose",
"work empagliflozin works",
"diabetic ketoacidosis consult",
"frequent urination due",
"moderate side effects",
"gliempaflozin met 125mg1000mg",
"results side effects",
"healthcare provider timing",
"insulin production directions",
"enhances insulin sensitivity"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2047,
"imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:34:26.615Z",
"updatedon": "2025-03-22T10:19:44.132Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ",
"category": "",
"tags": [
"empagliflozin 12.5 mg+metformin 500 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}